ImportRefusal LogoImportRefusal

Daiichi Sankyo Healthcare Co, LTD

⚠️ High Risk

FEI: 3015210379 • Nihomba, Tokyo • JAPAN

FEI

FEI Number

3015210379

📍

Location

Nihomba, Tokyo

🇯🇵

Country

JAPAN
🏢

Address

3chome 14-10, Nihombashi; Cho, Nihomba, Tokyo, Japan

High Risk

FDA Import Risk Assessment

61.7
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

15
Total Refusals
5
Unique Violations
5/30/2025
Latest Refusal
9/30/2015
Earliest Refusal

Score Breakdown

Violation Severity
73.3×40%
Refusal Volume
44.6×30%
Recency
87.1×20%
Frequency
15.5×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7512×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1182×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32602×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 801.15(c)(1)

4711×

CSTIC LBLG

The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.

4731×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

Refusal History

DateProductViolationsDivision
5/30/2025
64PBA04TRANEXAMIC ACID (HEMOSTATIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/15/2023
60LBA01ACETAMINOPHEN (ANALGESIC)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/4/2023
54YCE99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
75UNAPPROVED
Division of West Coast Imports (DWCI)
9/27/2023
54YCA99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
3260NO ENGLISH
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/12/2023
55RP99PHARMACEUTIC NECESSITIES, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/14/2022
66NDY11LURASIDONE HYDROCHLORIDE (TRANQUILIZER (ANTI-PSYCHOTIC) - PART II)
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/21/2021
62UBK19PHOLCODINE (ANTI-TUSSIVE/COLD)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/8/2020
66VAA99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/3/2019
53LD06MOISTURIZING (SKIN CARE PREPARATIONS)
473LABELING
Division of Southeast Imports (DSEI)
6/27/2019
53LY08PASTE MASKS (MUD PACKS) (SKIN CARE PREPARATIONS)
3260NO ENGLISH
Division of West Coast Imports (DWCI)
12/29/2017
60LDY01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/15/2017
66VCY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/15/2017
61FCA56CLARITHROMYCIN (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/15/2017
66VCY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/30/2015
53LF06MOISTURIZING (SKIN CARE PREPARATIONS)
471CSTIC LBLG
Detroit District Office (DET-DO)

Frequently Asked Questions

What is Daiichi Sankyo Healthcare Co, LTD's FDA import refusal history?

Daiichi Sankyo Healthcare Co, LTD (FEI: 3015210379) has 15 FDA import refusal record(s) in our database, spanning from 9/30/2015 to 5/30/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Daiichi Sankyo Healthcare Co, LTD's FEI number is 3015210379.

What types of violations has Daiichi Sankyo Healthcare Co, LTD received?

Daiichi Sankyo Healthcare Co, LTD has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Daiichi Sankyo Healthcare Co, LTD come from?

All FDA import refusal data for Daiichi Sankyo Healthcare Co, LTD is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.